Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 94.47
+4.47 (4.97%)
Sep 30, 2026, 3:00 PM CST
Beijing Hotgen Biotech Revenue
Beijing Hotgen Biotech had revenue of 151.72M CNY in the quarter ending June 30, 2026, with 37.67% growth. This brings the company's revenue in the last twelve months to 469.17M, up 1.03% year-over-year. In the year 2025, Beijing Hotgen Biotech had annual revenue of 404.88M, down -20.58%.
Revenue (ttm)
469.17M
Revenue Growth
+1.03%
P/S Ratio
17.75
Revenue / Employee
449.83K
Employees
1,043
Market Cap
8.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 404.88M | -104.90M | -20.58% |
| Dec 31, 2024 | 509.78M | -38.06M | -6.95% |
| Dec 31, 2023 | 547.84M | -3.01B | -84.60% |
| Dec 31, 2022 | 3.56B | -1.81B | -33.76% |
| Dec 31, 2021 | 5.37B | 4.86B | 945.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.